Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Clin Infect Dis
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Hepatology
1 J Clin Microbiol
5 J Hepatol
1 J Med Virol
5 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
1 PLoS One
2 Transplant Proc
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Clin Infect Dis

  1. ONOFRIO FQ, Cooper C, Borgia SM, Vachon ML, et al
    Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
    Clin Infect Dis. 2021;72:e799-e805.
    PubMed         Abstract available

    Dig Dis Sci

  2. VAZ K, Little R, Majeed A, Kemp W, et al
    Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07140.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  3. ALEM SA, Eletreby R, Abdellatif Z, Ramadan A, et al
    Long-term clinical outcomes in sustained responders with chronic hepatitis C after treatment with direct-acting antivirals.
    Eur J Gastroenterol Hepatol. 2021 Jul 6. pii: 00042737-900000000-97183.
    PubMed         Abstract available


  4. KIM OK, Nam DE, Hahn YS
    The Panx1/P2X4 pathway controls the secretion of miRNA-containing exosomes by HCV-infected hepatocytes.
    Hepatology. 2021 Jul 4. doi: 10.1002/hep.32042.
    PubMed         Abstract available

    J Clin Microbiol

  5. LU J, Huang Y, Wang P, Li Q, et al
    Dynamics of Hepatitis E Virus (HEV) Antibodies and Development of a Multifactorial Model To Improve the Diagnosis of HEV Infection in Resource-Limited Settings.
    J Clin Microbiol. 2021;59.
    PubMed         Abstract available

    J Hepatol

  6. SINGAL AG, Lampertico P, Nahon P
    Epidemiology and surveillance for hepatocellular carcinoma: New trends.
    J Hepatol. 2020;72:250-261.
    PubMed         Abstract available

  7. BOLIA R, Srivastava A
    The Search For Optimum Thiopurine Metabolite Levels in Autoimmune Hepatitis Continues....
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01890.

  8. LLEWELLYN HP, Arat S, Gao J, Wen J, et al
    T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model.
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01887.
    PubMed         Abstract available

  9. GRANITO A, Muratori P, Muratori L
    Acute-on-chronic liver failure: a complex clinical entity in patients with autoimmune hepatitis.
    J Hepatol. 2021 Jul 3. pii: S0168-8278(21)01884.

  10. VIBERT E, Schwartz M, Olthoff KM
    Advances in resection and transplantation for hepatocellular carcinoma.
    J Hepatol. 2020;72:262-276.
    PubMed         Abstract available

    J Med Virol

  11. WEI MT, Le MH, Landis C, Trinh H, et al
    Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C.
    J Med Virol. 2021 Jul 5. doi: 10.1002/jmv.27168.
    PubMed         Abstract available

    J Viral Hepat

  12. LOU T, Li B, Xiong P, Jin C, et al
    External Validation of Hepatocellular Carcinoma Risk Scores in Patients with Chronic Hepatitis B Virus Infection in China.
    J Viral Hepat. 2021 Jul 4. doi: 10.1111/jvh.13569.
    PubMed         Abstract available

  13. KAMALAPIRAT T, Ungtrakul T
    Reply to "Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B".
    J Viral Hepat. 2021 Jul 5. doi: 10.1111/jvh.13566.
    PubMed         Abstract available

  14. ERICE A, Varillas-Delgado D, Caballero C
    Prevalence and characteristics of hepatitis C virus infection detected by extended screening of working-age adults in Madrid (Spain).
    J Viral Hepat. 2021 Jul 5. doi: 10.1111/jvh.13564.
    PubMed         Abstract available

  15. LI J, Qu L, Sun X, Liu Y, et al
    Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg positive chronic hepatitis B naive patients.
    J Viral Hepat. 2021 Jul 6. doi: 10.1111/jvh.13571.
    PubMed         Abstract available

  16. VARCHETTA S, Mele D, D'Ambrosio R, Perbellini R, et al
    A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C.
    J Viral Hepat. 2021 Jul 6. doi: 10.1111/jvh.13570.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  17. BIXLER D, Annambhotla P, Montgomery MP, Mixon-Hayden T, et al
    Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:961-966.
    PubMed         Abstract available

    Pediatr Infect Dis J

  18. POKORSKA-SPIEWAK M, Dobrzeniecka A, Oldakowska A, Marczynska M, et al
    Effective Treatment of Chronic Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir in 2 Teenagers With HIV Coinfection: A Brief Report.
    Pediatr Infect Dis J. 2021 Jul 6. pii: 00006454-900000000-95778.
    PubMed         Abstract available

    PLoS One

  19. LLORENS-REVULL M, Costafreda MI, Rico A, Guerrero-Murillo M, et al
    Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
    PLoS One. 2021;16:e0254243.
    PubMed         Abstract available

    Transplant Proc

  20. CHANG SH
    Prevention of HBV Recurrence After Liver Transplant: Long-Term Results.
    Transplant Proc. 2021 May 13. pii: S0041-1345(21)00253.
    PubMed         Abstract available

  21. VAN HERCK J, Verbeek J, van Malenstein H, Laleman W, et al
    Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study.
    Transplant Proc. 2021;53:1674-1681.
    PubMed         Abstract available


  22. GOSSET A, Diallo MY, Betsem E, Schaeffer L, et al
    Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NeoVac Study).
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00809.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.